Is TuHURA Biosciences, Inc. profitable?

TuHURA Biosciences, Inc. is not currently profitable: it reported a net loss of $30.9M over the trailing twelve months.

What is TuHURA Biosciences, Inc.'s earnings per share?

TuHURA Biosciences, Inc.'s diluted EPS over the trailing twelve months is $-0.61.

Where does TuHURA Biosciences, Inc.'s income statement data come from?

Every line is extracted from TuHURA Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

TuHURA Biosciences, Inc. HURA Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Total revenue	$0—	$0—	$0—	$0—	$0—
Research and development	$21.18M+47.8%	$20.53M+54.0%	$18.45M+94.9%	$16.43M+96.0%	$14.33M+30.4%
General and administrative	——	——	$10M+186%	$9.03M+136%	$4.87M+26.1%
Depreciation and amortization	$80.68K-16.4%	$71.27K-38.9%	$66.36K-53.7%	$74.21K-53.2%	$96.46K-42.4%
Acquisition and integration costs	——	——	——	——	$749.3K—
Other operating expenses	$32.31M+61.1%	$31.8M+80.2%	$29.32M+126%	$26.32M+116%	$20.06M-35.4%
Total operating expenses	$32.31M+61.1%	$31.8M+80.2%	$29.32M+126%	$26.32M+116%	$20.06M-35.4%
Interest expense	——	——	——	——	——
Interest income	$57.41K-87.4%	$136.23K-62.3%	$299.81K+36.4%	$426.51K+289%	$455.09K+516%
Other income (expense), net	$1.38M-47.1%	$1.74M-25.4%	$4.19M+374%	$4.62M+393%	$2.62M+1,330%
Net income	-$30.92M-31.6%	-$30.05M-38.6%	-$29.29M-75.3%	-$27.76M-97.0%	-$23.5M+23.9%
Preferred stock dividends	$8.36K—	$8.36K—	——	——	——
Diluted earnings per share	-$0.61—	-$0.63—	——	——	——
Basic earnings per share	-$0.61—	-$0.63—	——	——	——
Weighted-average shares, diluted	203.2M+135%	186.6M+238%	157.3M+225%	118.8M—	86.4M—
Weighted-average shares, basic	203.2M+135%	186.6M+238%	157.3M+285%	118.8M+313%	86.4M—
Employee Retention Tax Credit	——	$113.57K—	——	——	——
Grant Income	——	$713.51K+1,138%	$727.91K+1,252%	$604.02K+1,107%	$295.77K+539%
Loss On Kineta Employee Separation Payments Assumed From Merger	——	$185.02K—	——	——	——
Accounts payable and other current liabilities	-$3.91M—	-$3.91M—	-$1.51M—	$6.31M—	——
Interest Income, Other	$57.41K-87.4%	$136.23K-62.3%	$299.81K+36.4%	$426.51K+289%	$455.09K+516%
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation	$27.62M+12.3%	$19.93M-33.1%	$15.84M—	$26.28M—	$24.59M—
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation	-$233.16K+96.8%	-$1.34M+77.9%	-$2.13M—	-$7.32M—	-$7.18M—
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation	-$27.3M-120%	-$27.63M-140%	-$24.67M—	-$15.48M—	-$12.39M—
Other Nonoperating Expense	——	——	——	——	——
Other income, net (Note 6)	$1.38M+140%	$1.74M+143%	$30.9K+101%	-$1.45M+12.9%	-$3.44M-3,560%
Payments of Ordinary Dividends, Preferred Stock and Preference Stock	$8.36K—	$8.36K—	——	——	——
Stock-based compensation	$7.8M+156%	$6.42M+228%	$5.36M+436%	$4.18M+392%	$3.05M+339%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Is TuHURA Biosciences, Inc. profitable?: TuHURA Biosciences, Inc. is not currently profitable: it reported a net loss of $30.9M over the trailing twelve months.
What is TuHURA Biosciences, Inc.'s earnings per share?: TuHURA Biosciences, Inc.'s diluted EPS over the trailing twelve months is $-0.61.
Where does TuHURA Biosciences, Inc.'s income statement data come from?: Every line is extracted from TuHURA Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.